Novo A/S (investor - Corporate Investor)

See something wrong or missing? Let us know
Offices:Hellerup

Novo A/S is a private limited liability company fully owned by the Novo Nordisk Foundation.

Besides being the major shareholder in the Novo Group companies, Novo A/S provides seed (Novo Seeds) and venture capital (Novo Ventures) to development stage companies and takes significant ownership positions in well-established companies, within life science, as well as manages a broad portfolio of financial assets.

Average round investment:66.54M USD
Average number per year:8.7
Distribution: 2025 (14)2024 (27)2023 (17)2022 (9)2021 (12) See the entire list
Mostly invests in: Denmark Denmark (49) Biotech (71)
See the entire list

Showing 3 of 96 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Novo A/S mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Novo A/S

Name Criteria
France Eurazeo
96%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma, Food Industry, Software Services, Hardware, Agriculture, Energy, Electronics, AI (big data), Social Responsibility, Wearable, Transportation
  • Similar business models: B2B, SAAS, B2C (Retail)
  • Common investees countries: Denmark, United Kingdom, Switzerland, Germany, Sweden, Netherlands, France, Belgium, Ireland, Finland
  • Active last 12 months: Yes
United Kingdom Felix Capital
96%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Pharma, Food Industry, Software Services, Agriculture, Energy, AI (big data), Social Responsibility, Transportation
  • Similar business models: B2B, SAAS, B2C (Retail)
  • Common investees countries: United Kingdom, Germany, Sweden, Netherlands, France, Belgium
  • Average number of deals per year: 8.2
United Kingdom Plural
96%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Software Services, Hardware, Agriculture, Energy, Electronics, AI (big data), Social Responsibility, Transportation
  • Similar business models: B2B, SAAS, B2C (Retail)
  • Common investees countries: Denmark, United Kingdom, Germany, Netherlands, France, Finland
  • Average number of deals per year: 8.2
China Tencent Holdings
96%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma, Food Industry, Software Services, Hardware, Energy, Electronics, AI (big data), Transportation
  • Similar business models: B2B, SAAS, B2C (Retail)
  • Common investees countries: Denmark, United Kingdom, Germany, Sweden, Netherlands, France, Ireland, Norway, Finland
  • Average number of deals per year: 8.0
France Aglaé Ventures
95%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Food Industry, Software Services, Hardware, Electronics, AI (big data), Transportation
  • Similar business models: B2B, SAAS, B2C (Retail)
  • Common investees countries: United Kingdom, Germany, France
  • Average number of deals per year: 7.3
United States Bessemer Venture Partners
95%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Food Industry, Software Services, Electronics, AI (big data), Transportation
  • Similar business models: B2B, SAAS, B2C (Retail)
  • Common investees countries: Denmark, United Kingdom, Switzerland, Germany, Sweden, Netherlands, France
  • Average number of deals per year: 7.0
United States Citigroup
95%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Software Services, Energy, AI (big data), Social Responsibility, Transportation
  • Similar business models: B2B, SAAS, B2C (Retail)
  • Common investees countries: United Kingdom, Switzerland, Germany, Sweden, France, Finland
  • Average number of deals per year: 6.8
Netherlands Forbion Capital Partners
95%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma, Food Industry, Software Services, Agriculture, AI (big data)
  • Similar business models: B2B, SAAS, B2C (Retail)
  • Common investees countries: Denmark, United Kingdom, Switzerland, Germany, Netherlands, France, Belgium, Ireland, Norway
  • Average number of deals per year: 6.7
Sweden Investment AB Kinnevik
95%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Food Industry, Software Services, Hardware, Agriculture, Energy, Electronics, AI (big data), Social Responsibility, Transportation
  • Similar business models: B2B, SAAS, B2C (Retail)
  • Common investees countries: Denmark, United Kingdom, Germany, Sweden, Ireland, Norway
  • Average number of deals per year: 6.8
United Kingdom British Patient Capital
95%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma, Software Services, Hardware, Energy, Electronics, AI (big data)
  • Similar business models: B2B, SAAS, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 6.6

News about Novo A/S


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Top